Adaptive Biotechnologies Reports Q4 Loss, Beats Estimates
Adaptive Biotechnologies Corp. (ADPT) reported a narrower fourth-quarter loss on Tuesday, topping Wall Street expectations.
Q4 Results:
* Loss: $33.7 million ($0.23 per share)
* Revenue: $47.5 million
* Analyst Estimates: Loss of $0.26 per share; Revenue of $46.4 million
Full-Year Results:
* Loss: $159.5 million ($1.08 per share)
* Revenue: $179 million
Stock Performance:
ADPT shares have surged 99% in the past year, including a 30% gain since the start of 2023. In Tuesday's closing minutes, they were up 1.56% to $7.80.